Personalis, Inc. (PSNL)
USD 3.56
(-7.29%)
USD 3.56
(-7.29%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -108.29 Million USD | 4.43% |
| 2022 | -113.31 Million USD | -73.73% |
| 2021 | -65.22 Million USD | -58.01% |
| 2020 | -41.28 Million USD | -64.57% |
| 2019 | -25.08 Million USD | -26.14% |
| 2018 | -19.88 Million USD | 15.73% |
| 2017 | -23.59 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -12.8 Million USD | 1.28% |
| 2024 Q1 | -12.96 Million USD | 51.22% |
| 2023 Q2 | -23.95 Million USD | 16.41% |
| 2023 Q3 | -29.09 Million USD | -21.47% |
| 2023 FY | -108.29 Million USD | 4.43% |
| 2023 Q1 | -28.65 Million USD | 7.75% |
| 2023 Q4 | -26.58 Million USD | 8.64% |
| 2022 Q3 | -26.49 Million USD | 3.83% |
| 2022 FY | -113.31 Million USD | -73.73% |
| 2022 Q1 | -28.2 Million USD | -39.66% |
| 2022 Q4 | -31.06 Million USD | -17.27% |
| 2022 Q2 | -27.54 Million USD | 2.35% |
| 2021 FY | -65.22 Million USD | -58.01% |
| 2021 Q1 | -12.4 Million USD | 7.02% |
| 2021 Q4 | -20.19 Million USD | -14.31% |
| 2021 Q3 | -17.67 Million USD | -18.17% |
| 2021 Q2 | -14.95 Million USD | -20.55% |
| 2020 FY | -41.28 Million USD | -64.57% |
| 2020 Q4 | -13.34 Million USD | -39.77% |
| 2020 Q3 | -9.54 Million USD | -3.13% |
| 2020 Q2 | -9.25 Million USD | -1.27% |
| 2020 Q1 | -9.13 Million USD | -37.53% |
| 2019 Q3 | -6.88 Million USD | -17.31% |
| 2019 Q1 | -5.68 Million USD | -59.92% |
| 2019 Q2 | -5.86 Million USD | -3.24% |
| 2019 Q4 | -6.64 Million USD | 3.49% |
| 2019 FY | -25.08 Million USD | -26.14% |
| 2018 Q1 | -5.37 Million USD | 0.0% |
| 2018 Q3 | -3.64 Million USD | 50.23% |
| 2018 Q4 | -3.55 Million USD | 2.36% |
| 2018 FY | -19.88 Million USD | 15.73% |
| 2018 Q2 | -7.31 Million USD | -36.09% |
| 2017 FY | -23.59 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Bionano Genomics, Inc. | -232.49 Million USD | 53.42% |
| Prenetics Global Limited | -62.72 Million USD | -72.655% |
| Star Equity Holdings, Inc. | -1.54 Million USD | -6895.866% |
| CareDx, Inc | -190.28 Million USD | 43.087% |
| Exact Sciences Corporation | -204.14 Million USD | 46.952% |
| Exagen Inc. | -23.68 Million USD | -357.157% |
| Inotiv, Inc. | -105.14 Million USD | -3.002% |
| Guardant Health, Inc. | -479.44 Million USD | 77.412% |
| Biodesix, Inc. | -52.14 Million USD | -107.678% |
| BioNexus Gene Lab Corp. | -2.62 Million USD | -4019.218% |
| Precipio, Inc. | -5.85 Million USD | -1750.265% |
| iSpecimen Inc. | -11.09 Million USD | -875.685% |
| Natera, Inc. | -434.8 Million USD | 75.093% |
| Aspira Women's Health Inc. | -16.69 Million USD | -548.868% |
| Standard BioTools Inc. | -74.65 Million USD | -45.06% |
| 23andMe Holding Co. | -666.7 Million USD | 83.757% |
| Castle Biosciences, Inc. | -57.46 Million USD | -88.452% |
| Aclaris Therapeutics, Inc. | -88.48 Million USD | -22.395% |
| Applied DNA Sciences, Inc. | -9.94 Million USD | -988.724% |
| OpGen, Inc. | -32.66 Million USD | -231.499% |
| T2 Biosystems, Inc. | -50.07 Million USD | -116.259% |
| Myriad Genetics, Inc. | -112 Million USD | 3.307% |
| ICON Public Limited Company | 612.33 Million USD | 117.686% |
| NeoGenomics, Inc. | -87.96 Million USD | -23.108% |
| Star Equity Holdings, Inc. | -1.54 Million USD | -6895.866% |
| IDEXX Laboratories, Inc. | 845.04 Million USD | 112.815% |
| RadNet, Inc. | 3.04 Million USD | 3657.687% |
| MDxHealth SA | -43.1 Million USD | -151.267% |
| Psychemedics Corporation | -4.15 Million USD | -2507.029% |
| Illumina, Inc. | -1.16 Billion USD | 90.672% |
| Check-Cap Ltd. | -17.56 Million USD | -516.439% |
| Twist Bioscience Corporation | -208.72 Million USD | 48.116% |
| DarioHealth Corp. | -59.42 Million USD | -82.234% |
| Fulgent Genetics, Inc. | -167.82 Million USD | 35.471% |
| Sera Prognostics, Inc. | -36.24 Million USD | -198.814% |
| ENDRA Life Sciences Inc. | -10.06 Million USD | -976.474% |
| OPKO Health, Inc. | -188.86 Million USD | 42.659% |
| Medpace Holdings, Inc. | 282.81 Million USD | 138.293% |
| Neogen Corporation | -9.42 Million USD | -1049.517% |
| Intelligent Bio Solutions Inc. | -10.15 Million USD | -966.246% |
| Prenetics Global Limited | -62.72 Million USD | -72.655% |
| Mainz Biomed B.V. | -26.29 Million USD | -311.839% |
| bioAffinity Technologies, Inc. | -7.93 Million USD | -1264.443% |
| Trinity Biotech plc | -24.01 Million USD | -350.895% |
| Neuronetics, Inc. | -30.18 Million USD | -258.727% |
| Sotera Health Company | 51.37 Million USD | 310.791% |
| bioAffinity Technologies, Inc. | -7.93 Million USD | -1264.443% |